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Although previous studies have demonstrated that diabetic
nephropathy is attributable to early extracellular matrix
accumulation in glomerular mesangial cells, the molecular
mechanism by which high glucose induces matrix protein
deposition remains not fully elucidated. Rat mesangial cells
pretreated with or without inhibitors were cultured in
high-glucose or advanced glycation end product (AGE)
conditions. Streptozotocin-induced diabetic rats were given
superoxide dismutase (SOD)-conjugated propylene glycol to
scavenge superoxide. Transforming growth factor (TGF)-b1,
fibronectin expression, Ras, ERK, p38, and c-Jun activation of
glomerular mesangial cells or urinary albumin secretion were
assessed. Superoxide, not nitric oxide or hydrogen peroxide,
mediated high glucose- and AGE-induced TGF-b1 and
fibronectin expression. Pretreatment with diphenyliodonium,
not allopurinol or rotenone, reduced high-glucose and AGE
augmentation of superoxide synthesis and fibronection
expression. High glucose and AGEs rapidly enhanced Ras
activation and progressively increased cytosolic ERK and
nuclear c-Jun activation. Inhibiting Ras by manumycin A
reduced the stimulatory effects of high glucose and AGEs on
superoxide and fibronectin expression. SOD or PD98059
pretreatment reduced high-glucose and AGE promotion of
ERK and c-Jun activation. Exogenous SOD treatment in
diabetic rats significantly attenuated diabetes induction of
superoxide, urinary albumin excretion, 8-hydroxy-20-
deoxyguanosine, TGF-b1, and fibronectin immunoreactivities
in renal glomerular mesangial cells. Ras induction of
superoxide activated ERK-dependent fibrosis-stimulatory
factor and extracellular matrix gene transcription of
mesangial cells. Reduction of oxidative stress by scavenging
superoxide may provide an alternative strategy for
controlling diabetes-induced early renal injury.
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Diabetic nephropathy is characterized by excessive deposition
of extracellular matrix in the kidney, causing glomerular
mesangial expansion and fibrosis.1 Previous studies have
attributed diabetic nephropathy to hyperglycemia-induced
deposition of extracellular matrix, glycosylation of matrix
proteins, mesangial cell dysfunction, and global glomerular
sclerosis, leading to promotion of endothelial albumin
permeability.2–4 High glucose is reported to alter renal
remodeling-stimulatory or -inhibitory factor activities by
increasing intercellular thrombospondin I5 or downregulat-
ing pigment epithelium-derived factor expression6 to control
the action of transforming growth factor (TGF)-b1 on matrix
protein synthesis in rodent and human mesangial cells.
Advanced glycation end products (AGEs) synthesized by
Amadori rearrangement of excess glucose and free amino
acid in chronic hyperglycemia have been implicated as
secondary irreversible metabolic products of hyperglycemia.7
We have shown that AGEs are coincided with increased
inflammatory cytokine secretion in patients with chronic
renal failure.8 AGEs have been found to promote cell
apoptosis, vascular dysfunction, and tubular epithelial-
myofibroblast transient, resulting in renal failure.9–11 The
administration of AGE inhibitor has been reported to inhibit
progression of extracellular matrix accumulation and glo-
merular injury in mice.12
Alteration of reactive radicals has been shown to regulate
diabetes-induced renal injury. Increased oxidative stress is
reported to coincide with vascular dysfunction, lipid
peroxidation, and glyco-oxidative molecule production in
diabetes.13,14 Patients with diabetic nephropathy are asso-
ciated with decreased antioxidant enzyme expression.15
Increased hydrogen peroxide inhibits Naþ /glucose transpor-
ter activity in renal proximal tubular cells exposed to high-
glucose conditions.16 Decreased nitric oxide bioavailability or
formation of cytotoxic peroxynitrite seems to be associated
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with overproduction of superoxide in high glucose, leading
to human glomerular endothelial cell dysfunction and
patients with diabetic nephropathy.17 Upregulated reactive
oxygen radicals and TGF-b1 synthesis have been found in
glomerular mesangial cells cultured in high glucose.18,19
Reduction of oxidative stress reportedly alleviates high
glucose-induced apoptosis of endothelial cells and mesangial
cells,20,21 implying that reactive radicals act as potent
mediators controlling high-glucose induction of early
glomerular mesangial injury. However, the molecular me-
chanisms and signaling transduction by which high glucose
induces early mesangial cell dysfunction are not clearly
understood. We hypothesize that oxidative radicals mediate
high-glucose and glyco-oxidative molecule (AGEs) activation
of intracellular signaling pathway to induce excess extra-
celluar matrix accumulation in mesangial cells. Reduction of
oxidative stress by cell-permeable superoxide dismutase
(SOD)-conjugated propylethyl glycol (SOD-PEG) may ame-
liorate diabetes promotion of fibrosis-stimulatory factor and
matrix protein expression in mesangial cells.
The purposes of this study are as follows: investigate which
species of oxidative radicals are involved in regulating high-
glucose and AGE induction of excess extracellular matrix
synthesis, what the signal transduction pathways are
responsible for these biological reactions, and determine
whether antioxidant treatment by SOD-PEG alleviates
oxidative damage, excess TGF-b1, and fibronectin synthesis
of renal glomerular mesangial cell in streptozotocin-induced
diabetic rats.
RESULTS
Superoxide, but not nitric oxide or hydrogen peroxide,
mediated high-glucose and AGE promotion of TGF-b1 and
fibronectin expression
Mesangial cells were cultured in 35 mM D-glucose or 100 mg/
ml AGEs for 8 days. Real-time polymerase chain reaction
(PCR) results showed that D-glucose or AGEs significantly
increased TGF-b1 (Figure 1a) and fibronectin gene expres-
sion in 1 day (Figure 1b). High glucose and AGEs elicited the
highest promoting effects on TGF-b1 and fibronectin gene
expression at 2 days after treatment, respectively (Figure 1).
We further investigated the action mechanisms of high-
glucose and AGE promotion of fibronectin expression.
Pretreatments with 100 mM N-nitro-L-arginine methyl ester
or 500 U/ml catalase did not significantly affect high-glucose
and AGE promotion of TGF-b1 (Figure 2a) and fibronectin
mRNA expression (Figure 2b). Pretreatment with 500 U/ml
SOD significantly reduced the enhancing effect of high
glucose and AGEs on TGF-b1 (Figure 2a) and fibronectin
expression (Figure 2b), indicating that superoxide mediates
TGF-b1 and fibronectin synthesis in mesangial cells.
Diphenyloniodium pretreatment reduced high glucose- and
AGE-induced superoxide, TGF-b1, and fibronectin expression
Results of SOD-inhibitable cytochrome c reduction assays
showed that high glucose and AGEs (Figure 3a) rapidly
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Figure 1 | High glucose and AGEs increased TGF-b1 and
fibronectin mRNA expression of mesangial cells. Cells (1 106
cell/well, in six-well plate) were cultured in medium containing 35 mM
D-glucose or 100 mg/ml AGEs for 8 days. The results graphed
represent the relative abundance of the (a) TGF-b1 and (b)
fibronectin gene by real-time PCR normalized to housekeeping
gene b-actin. Experimental results are presented as means7s.e.’s
calculated from six-paired triplicate experiments. Symbols: ., vehicle;
K, high glucose-treated group; and, J, AGE-treated group.
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Figure 2 | Superoxide, but not hydrogen peroxide or nitric oxide,
mediated high glucose- or AGE-enhanced TGF-b1 and fibronectin
mRNA expression of mesangial cells. Cell cultures (1 106 cell/well,
in six-well plate) were pretreated with 500 U/ml SOD-PEG or 500 U/ml
catalase-PEG or 100 mM N-nitro-L-arginine methyl ester (L-NAME) and
subjected to 35 mM D-glucose or 100 mg/ml AGE treatment for 2 days.
The experimental results graphed represent the relative abundance
of the TGF-b1 and fibronectin gene by real-time PCR normalized to
housekeeping gene b-actin. Experimental results are presented as
means7s.e.’s errors calculated from six-paired triplicate experiments.
*, #, and þ show differences (Po0.05) from the vehicle, high glucose-,
and AGE-treated groups, respectively.
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increased superoxide synthesis in 1 h. Pretreatment with
rotenone or allopurinol did not significantly affect high-
glucose and AGE promotion of superoxide (Figure 3b), TGF-
b1 (Figure 3c), and fibronectin synthesis (Figure 3d).
Pretreatment with diphenyloniodium (DPI) significantly
reduced the enhancing effect of high glucose and AGEs on
superoxide (Figure 3b), TGF-b1 (Figure 3c), and fibronectin
expression (Figure 3d), indicating that nicotinamide adenine
dinucleotide phosphate (NADPH) oxidase is responsible for
regulating superoxide induction.
Superoxide mediated high glucose- and AGE-increased
cytosolic extracellular signal-regulated protein kinase and
nuclear c-Jun phosphorylation
Immunoblotting results showed that AGE and high-glucose
treatments promoted cytosolic extracellular signal-regulated
protein kinase (ERK) (Figure 4a) and nuclear c-Jun
activation in 6 h (Figure 4c). AGE and high-glucose
treatments did not evidently alter p38 activation throughout
the study period (Figure 4b). Moreover, high glucose and
AGEs rapidly increased Ras activation in 1 h (Figure 5a).
Pretreatment of DPI or SOD did not evidently affect high-
glucose or AGE promotion of Ras activation (Figure 5b).
Inhibiting Ras activity by manumycin A significantly reduced
the promoting effect of high glucose and AGEs on superoxide
synthesis in 1 h (Figure 5c).
Inhibition of superoxide synthesis by SOD or DPI or
suppression of ERK activity by PD98059 or inhibition of Ras
activity by manumycin A significantly reduced the enhancing
effect of high glucose and AGEs on cytosolic ERK (Figure 6a),
and nuclear c-Jun activation (Figure 6b), TGF-b1 (Figure 6c),
and fibronectin mRNA expression (Figure 6d). These
findings suggest that high glucose and AGEs through Ras
and NADPH oxidase induce superoxide to activate cytosolic
ERK and nuclear c-Jun.
Exogenous SOD alleviated urinary albumin secretion,
superoxide level, TGF-b1, fibronectin, and 8-hydroxy-20-
deoxyguanosine expression of kidney in diabetic rats
In comparison with the normal control group, diabetes
significantly increased systemic superoxide (Figure 7a), which
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Figure 3 | High glucose and AGEs increased superoxide synthesis by mesangial cells. (a) High glucose and AGEs rapidly increased
superoxide synthesis in 1 h Inhibition of superoxide by DPI, but not by rotenone or allopurinol, reduced high glucose-augmented
(b) superoxide production in 1 h, (c) TGF-b1, and (d) fibronectin mRNA expression in 2 days. Cell cultures (1 106 cells/well, in six-well plate)
were pretreated with 20mM DPI or 30 mM allopurinol or 30 mM rotenone and subjected to 35 mM D-glucose and 100mg/ml AGE for 2 days. The
graphed results represent the relative abundance of TGF-b1 and fibronectin genes by real-time PCR normalized to housekeeping gene b-actin.
Experimental results are presented as means7s.e.’s calculated from six-paired triplicate experiments. *, #, and þ show differences (Po0.05)
from the vehicle, high glucose-, and AGE-treated groups, respectively.
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Figure 4 | High glucose or AGEs increased cytosolic ERK and
nuclear c-Jun activation. High glucose and AGEs did increase
(a) cytosolic ERK and (c) nuclear c-Jun activation but not evidently
alter (b) p38 activation. Cytosolic and nuclear fractions of cell lysates
from cell cultures with or without 35 mM glucose or 100mg/ml AGE
treatment were subjected to Western blot assay. Immunoblotting of
cytosolic ERK, p38, and nuclear c-Jun showed equal loadings and
transfer for all lanes. All blots represent at least three experiments,
each with comparable results.
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coincided with urinary albumin excretion (Figure 7b).
Exogenous 50 U/kg/day SOD-PEG treatments significantly
reduced the promoting effect of diabetes on systemic
superoxide levels (Figure 7a) and urinary albumin excretion
(Figure 7b). Immunoblotting showed that diabetes increased
TGF-b1 and fibronectin levels in kidney tissue (Figure 7c).
Superoxide easily reacts with nucleotide, resulting in DNA
damage to form 8-hydroxy-20-deoxyguanosine (a marker of
DNA oxidative damage). We found that diabetes promoted
8-hydroxy-20-deoxyguanosine expression in kidney tissue.
SOD treatment alleviated diabetes promotion of TGF-b1,
fibronectin, and 8-hydroxy-20-deoxyguanosine expression
(Figure 7c).
In the absence of primary antibodies, no immunostaining
of TGF-b1, fibronectin, or 8-hydroxy-20-deoxyguanosine was
visible (Figure 8). Mesangial cells in glomeruli showing
positive for immuno-expression exhibited brown color in the
cell peripheri and cytoplasm. In the control group, cells
located at the glomeruli in renal cortex expressed weak
fibronectin and TGF-b1 expression. In the diabetes group,
mesangial cells displayed strong fibronectin and TGF-b1
expression (Figure 8). Cells positive for 8-hydroxy-20-
deoxyguanosine displayed brown staining in nuclei. Diabetes
apparently induced 8-hydroxy-20-deoxyguanosine expression
of mesangial cells in glomeruli (Figure 8). Mesangial cells
expressed slight 8-hydroxy-20-deoxyguanosine, TGF-b1, and
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mRNA expression. (a, b) Cell cultures were pretreated with 500 U/ml
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Figure 7 | Exogenous SOD abolished diabetic renal damages in
rats. Exogenous SOD abolished the enhancing effect of diabetes on
(a) systemic superoxide levels and (b) urinary albumin secretion in
rats. (c) Exogenous SOD reduced the promoting effect of diabetes on
TGF-b1, fibronectin, and 8-hydroxy-20-deoxyguanosine levels in renal
tissue. Diabetic rats received 50 U/kg/day SOD-PEG treatment for 28
days. Systemic superoxide synthesis was measured by SOD-inhibi-
table cytochrome c reduction of mononuclear cells harvested from
peripheral blood. Albumin and creatinine levels in urine were assayed
using their respective assay kits. Immunoblotting of actin showed
equal loadings and transfer for all lanes. Experimental results are
presented as means7s.e.’s calculated from eight rats. * and #,
respectively, show differences from normal and DM-vehicle groups,
Po0.05. Symbols: J, control group; ., DM rats with vehicle
treatment; and, ,, DM rats with SOD-PEG treatment.
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fibronectin in diabetic renal cortex after SOD treatment
(Figure 8). Immunohistomorphometry results showed that
diabetes significantly increased TGF-b1, fibronectin, and
8-hydroxy-20-deoxyguanosine expression of glomerular me-
sangial cells compared with those in control group (Table 1).
Exogenous SOD treatment significantly downregulated
oxidative DNA damages, which coincided with reduced
TGF-b1 and fibronectin in the renal glomeruli of diabetic rats
(Table 1).
DISCUSSION
In this study, elevations in TGF-b1 and fibronectin levels in
mesangial cell cultures followed high-glucose and AGE
stresses, which induced membrane-bound Ras- and NADPH
oxidase-dependent superoxide. This reactive oxygen radical
progressively activated cytosolic ERK and nuclear c-Jun.
Although several previous studies have demonstrated that
excess extracellular matrix expansion and increased TGF-b1
levels in mesangial cells impair glomerular function leading
to diabetic nephropathy,22–24 mechanisms underlying high
glucose-induced extracellular matrix remodeling of renal
mesangial cells are not well understood. Our current findings
provide evidence that renal mesangial cells respond to high
glucose and AGEs by raising superoxide mediation of
intracellular signal transduction to promote fibrosis-stimu-
latory factor and extracellular matrix gene transcription. We
propose that it is the increased oxidative stress and fibrosis
response of mesangial cells that brings about the pathogenesis
of diabetes-induced early renal injury.
High glucose and AGEs have been found to disturb cell
homeostasis and bioactive molecule influx,9 possibly indicat-
ing that bioactive molecules may initialize intracellular signal.
In this study, superoxide, but not hydrogen peroxide or nitric
oxide, mediated TGF-b1 and fibronectin expression of
mesangial cells following high-glucose and AGE stresses. In
contrast to previous studies, which demonstrated high
glucose-induced mitochondria-dependent superoxide synth-
esis in human mesangial cells,25 we showed that NADPH
oxidase was responsible for high glucose- and AGE-induced
superoxide production. These findings are based on the facts
that superoxide synthesis, TGF-b1, and fibronectin expres-
sion were inhibited by DPI, but not by rotenone or
allopurinol. We speculate that the regulatory effect of high
glucose and AGEs on superoxide synthesis is dependent on
the model system and cell type used. Our findings are in
agreement with those in previous studies, which have
demonstrated that NADPH-dependent oxidoreductases are
active in non-phagocytic cells and act as generators of redox
signal in response to stresses.26
Inhibiting Ras activity by manumycin A reduced the
stimulatory effect of high glucose and AGEs on Ras activation
and subsequently reduced superoxide, ERK phosphorylation,
and fibronectin levels. We propose that membrane-bound
Ras acts as a crucial regulator to transmit extracellular stress
by increasing redox reaction and progressively activating
intracellular signal transduction pathways. Previous studies
have demonstrated that ERK is involved in regulating reactive
oxygen radical-induced apoptosis of proximal tubular cells.27
Mutation of the alkaline phosphatase-1-binding site or
alkaline phosphatase-1 inhibitor abrogated high glucose-
induced TGF-b promoter activity.28 The PD98059 inhibition
of ERK activity and SOD scavenging of superoxide reduced
the enhancing effect of high glucose and AGEs on nuclear
c-Jun activation and TGF-b1 and fibronectin expression,
suggesting that ERK is an important oxidant-sensitive
regulator able to transmit signal imparted by high glucose
into the nuclei to activate cascades of fibrosis-stimulatory
factor and extracellular matrix gene transcription. We cannot
exclude the possibilities that AGEs and high-glucose activa-
tion of ERK and fibrosis factor gene transcription may be
directly or indirectly regulated by redox reactions or other
membrane-bound signaling molecules. We suggest that Ras
pathway is, at least in part, responsible for superoxide, TGF-
b1, and fibronectin production of renal mesangial cells after
high-glucose or AGE stress.
Few previous studies have focused on the influence of high
glucose-induced oxidative stress on the kidney microenvir-
Normal
DM+SOD
Negative control
DM
8-OHdG TGF-1 Fibronectin
Figure 8 | Immunohistochemical photograph of glomeruli in
diabetic rats with or without SOD-PEG treatment. In comparison
with the control group, mesangial cells at glomeruli in diabetic
kidneys expressed stronger TGF-b1, fibronectin, and 8-hydroxy-20-
deoxyguanosine immunostaining. Decreased TGF-b1, fibronectin,
and 8-hydroxy-20-deoxyguanosine were observed in diabetic rats
after SOD-PEG treatment. Positive TGF-b1, fibronectin, and 8-
hydroxy-20-deoxyguanosine immunostained cells showed brown
color. Specimens were observed under original magnification  400.
Table 1 | Expression of TGF-b1, fibronectin, and 8-hydroxy-20-
deoxyguanosine in renal glomerular mesangial cells of
diabetic rats with or without SOD treatment
DM
Expression Normal Vehicle SOD-PEG
TGF-b1 4679 246725* 88719#
Fibronectin 3578 187729* 53711#
8-Hydroxy-20-deoxyguanosine 2476 197731* 94712#
DM, diabetes mellitus; SOD-PEG, superoxide dismutase-conjugated propylethyl
glycol; TGF, transforming growth factor.
Data are means7standard errors calculated from number of positive immuno-
stained cells in glomeruli per high-power field (0.75 mm2) in five areas from three
sections of eight rats.
* and #, respectively, show difference from normal and DM-vehicle group, Po0.05.
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onment in vivo. Redox control of TGF-b1 and fibronectin
expression in mesangial cells of the diabetic kidney have not,
to our knowledge, been previously reported. This study
provides the immunohistochemical evidence that mesangial
cells in diabetic kidneys displayed intensive 8-hydroxy-20-
deoxyguanosine associated with TGF-b1 and fibronectin
immunostaining. This phenomenon in the experimental
animal model is in line with that in the cell culture model. In
response to oxygen radical, DNA increases 8-hydroxy-20-
deoxyguanosine and impairs cellular metabolism and bio-
logical activities.29 In our studies, suppression of superoxide
levels by exogenous SOD evidently alleviated DNA oxidative
damage, TGF-b1, and fibronectin levels of renal glomerular
mesangial cells in diabetic rats. We suggest that renal
mesangial cells actively respond to high-glucose stress by
increasing TGF-b1 and fibronectin expression via superoxide
mediation of DNA oxidation and subsequently impair
mesangial cell function. Moreover, reduced urinary albumin
secretion in diabetic rats with exogenous SOD treatment also
provided a physiological explanation for oxidative stress
mediation of diabetic nephropathy.
The effect of antioxidants on controlling diabetic nephro-
pathy remains controversial. Previous studies have demon-
strated that increased antioxidant levels were observed in
streptozotocin-induced diabetic rats.30 High glucose likely
promoted SOD gene expression, but did not alter SOD
activity. Diabetes-induced lipid oxidation and glyco-oxida-
tion can impair SOD antioxidant activity.31 Recent studies
have demonstrated that vitamins C, lipoic acid, N-acetyl-
cysteine, and nordihydroguairetic acid are potent antioxidants
that alleviate diabetes-induced peripheral neuropathy, micro-
angiopathy, and glomerular proteinuria in patients and
experimental animals.32–35 In this experimental animal
model, exogenous cell-permeable SOD reduced diabetes-
induced systemic superoxide levels and early renal injury, as
demonstrated by intensive fibrosis-stimulatory factor and
extracellular matrix accumulation. Increase in antioxidant
activity by SOD gene overexpression or SOD-mimetic agents
protected experimental animals against diabetes-induced
glomerular injury and chronic renal failure.36,37 The in vitro
and in vivo findings in this study indicated that reduction of
oxidative stress by controlling superoxide synthesis alleviates
early diabetic nephropathy. Moreover, modulating Ras/ERK
signaling transduction may be an alterative strategy in the
future for controlling diabetes induction of oxidative stress
and early renal mesangial cell dysfunction.
Taken together, this study provided evidence that renal
mesangial cells respond to high-glucose and AGE stresses by
increasing Ras-dependent superoxide production and subse-
quently inducing cytosolic ERK and nuclear c-Jun activation,
leading to excess fibrosis-stimulatory factor and extracellular
matrix accumulation. This study also provides further
evidence that regulation of redox reactions or modulation
of high-glucose responsive fibrosis-stimulatory signaling
transduction can be an alternative strategy in the future for
preventing diabetes-induced nephropathy.
MATERIALS AND METHODS
Cell cultures
Rat mesangial cells (American Type Culture Center, CRL-2573TM)
were maintained in Dulbecco’s modified Eagle’s medium containing
10% fetal bovine serum (Gibco, Carlsbad, CA, USA) in a 5% CO2,
371C incubator for 6 days. Cells were harvested by trypsinization
and re-suspended in medium for further studies. Cell viability was
determined using trypan blue exclusion.
D-glucose and AGE treatment
Cells (1 106 cells/well, in six-well plate) were cultured in
Dulbecco’s modified Eagle’s medium, 10% fetal bovine serum
without or with 35 mM D-glucose or 100 mg/ml AGEs (Calbiochem,
La Jolla, CA, USA) for 48 h.38,39 To investigate the role of superoxide,
hydrogen peroxide, and nitric oxide in high-glucose and AGE
promotion of TGF-b1 and fibronectin expression, subconfluent cell
cultures were pretreated with or without the following inhibitors:
500 U/ml bovine erythrocyte SOD-PEG, catalase-PEG, 100 mM
N-nitro-L-arginine methyl ester, 20 mM DPI, 30 mM allopurinol, or
30 mM rotenone (Sigma-Aldrich, St Louis, MO, USA). In some
experiments, subconfluent cell cultures were pretreated with 10 mM
PD98059 (Calbiochem, La Jolla, CA, USA) or manumycin A
(Sigma-Aldrich, St Louis, MO, USA) to inhibit ERK or Ras activity
for 4 h before high-glucose and AGE treatment, respectively.
Superoxide production
Superoxide production of mesangial cell cultures (1 105 cells/well,
in 96-well plate) with or without high-glucose or AGE treatment or
mononuclear cells (1 106 cells/well, in 96-well plate) of peripheral
blood from diabetic rats with or without SOD treatment
were determined using horse heart cytochrome c reduction
assay in the absence and presence of SOD, and calculated from
the molar extinction coefficient of 0.0282 mM1 cm1 as described
previously.40
Reverse transcriptase-PCR
Total RNA was extracted and purified from 106 cells with and
without high glucose or AGE treatment using Tri reagent (Sigma
Chemical Inc., St Louis, MI, USA). In all, 1 mg of total RNA was
reversely transcribed (RT) into complementary DNA, followed by
PCR amplification using rat gene-specific primers: TGF-b1
(forward) (50-TGA GTG GCT GTC TTT TGA CG-30), (reverse)
(50-TGG GAC TGA TCC CAT TGA TT-30) (154-base pair expected);
fibronectin (forward) (50-GTG GCT GCC TTC AAC TTC TC-30),
(reverse) (50-AGT CCT TTA GGG CGG TCA AT-30) (231-base pair
expected); b-actin (forward) (50-CGC CAA CCG CGA GAA GAT-
30), b-actin (reverse) (50-CGT CAC CGG AGT CCA TCA-30) (168-
base pair expected). The parameters for reverse transcriptase-PCR
cycling were set as described previously.41
Real-time PCR
A volume of 25 ml of PCR mixture containing complementary DNA
template equivalent to 20 ng total RNA, 2.5 mM each of forward,
reverse primer, and 2 iQTM SYBR Green Supermix was amplified
using the iCycler iQs Real-time PCR Detection System (Bio-Rad
Laboratories, Hercules, CA, USA) with an initial melt at 951C for
5 min followed by 40 cycles at 941C for 15 s, 521C for 20 s, and 721C
for 30 s. Rat gene-specific primer oligonucleotide sequences were
used as follows: TGF-b1 (forward) (50-TGA GTG GCT GTC TTT
TGA CG-30), (reverse) (50-TGG GAC TGA TCC CAT TGA TT-30)
(154-base pair expected); fibronectin (forward) (50-GTG GCT GCC
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TTC AAC TTC TC-30), (reverse) (50-AGT CCT TTA GGG CGG
TCA AT-30) (231-base pair expected); b-actin (forward) (50-CGC
CAA CCG CGA GAA GAT-30), b-actin (reverse) (50-CGT CAC CGG
AGT CCA TCA-30) (168-base pair expected). The number of
amplification steps required to reach an arbitrary intensity threshold
(Ct) was computed. The relative gene expression levels were
presented as 2ðDctÞ, where DDCt¼Cttarget  Ctbactin. Fold change
for the treatment was defined as the relative expression, compared
with the vehicle, and was calculated as 2DDCt , where
DDCt ¼ DCttreatment  DCtvehicle .41
Immunoblotting
Membrane, cytosolic, and nuclear extracts of cell cultures were
prepared as described previously.42 Aliquots of cytosolic and nuclear
extracts (50 mg) were subjected to Western blot assay. Total cytosolic
ERK, p38, and nuclear c-Jun on the blots were recognized by
respective antibodies against ERK, p38, and c-Jun antibodies (Cell
Signaling Technology, Beverly, MA, USA), followed by horseradish
peroxidase-conjugated immunoglobulin G, and visualized with
chemiluminescence agents. Phosphorylated ERK, p38, and nuclear
c-Jun on the blots were recognized by anti-phospho-ERK, anti-
phospho-p38, and anti-phospho-c-Jun antibodies (Cell Signaling
Technology, Beverly, MA, USA). Ras activation was assessed using
the Ras activation assay kit (Upstate Biotechnology, Charlottesville,
VA, USA) according to the manufacturer’s instructions. Briefly, cell
lysates were precleared with glutathione-agarose, followed by
incubation with specific Raf Ras-binding domain conjugate. The
immunoprecipitates were subjected to immunoblotting. Activated
Ras proteins on the blots were recognized by using Ras antibodies as
the primary antibody and horseradish peroxidase-immunoglobulin
G as the secondary antibody, and visualized using chemilumines-
cence agents.42
Streptozotocin-induced diabetes
Male Wistar rats, 4-month old (National Experimental Animals
Production Center, Taiwan), were caged in pairs and maintained on
rodent chow and water ad libitum. Rats with diabetes were induced
by a single intraperitoneal injection of streptozotocin (50 mg/kg;
Sigma-Aldrich, St Louis, MO, USA).43 At 7 days after injection,
blood sugar was measured in tail blood samples. Rats with blood
sugar4300 mg/dl were defined as successful induction of diabetes
and then used for succeeding experiments. To equalize blood sugar
level at 200 mg/dl, diabetic rats were subcutaneously administered
intermittent-acting insulin (1–2 unit/kg; Montards Novo Nordisk
A/S) once a day until the animals were killed with an overdose of
sodium pentobarbital. All studies were approved by the Institutional
Animal Care and Use Committee of Chang Gung Memorial
Hospital.
Exogenous SOD–PEG administration
A total of 16 rats with diabetes were randomly divided into two
groups. Rats in each group received intraperitoneal injection with
50 U/kg/day SOD-PEG (n¼ 8) or normal saline (n¼ 8) for 28
consecutive days. Eight rats without streptozotocin injection were
used as normal control. Blood was harvested from each group of rats
via an intracardiac needle and processed to collect mononuclear cell
fraction using Ficoll-Paque gradient density separation as described
previously.40 At day 28, urinary albumin and creatinine levels were
measured using respective assay kits (Sigma-Aldrich, St Louis, MO,
USA) according to the manufacturer’s instructions. In a pilot study,
diabetic rats received intraperitoneal injections of 0, 10, 50, and
100 U/kg/day SOD–PEG for 28 days, respectively. Both 50 and
100 U/kg/day SOD-PEG treatment evidently reduced the promoting
effect of diabetes on systemic superoxide levels and urinary albumin
excretion compared with injections of 0 and 10 U/kg/day SOD-PEG.
Therefore, 50 U/kg/day SOD-PEG treatments were used for the
succeeding experiments. Normal and diabetic rats with or without
SOD-PEG treatment gained body weight throughout the study
period. Rats were killed with an overdose of pentobarbital sodium
and their kidneys were dissected. After perfusion with phosphate-
buffered saline, fresh kidney tissues were ground with a mortar and
pestle under liquid nitrogen, lysed with ice-cold phosphate-buffered
saline containing 1% NP-40, 0.1% sodium dodecyl sulfate, 0.5%
sodium deoxycholate, 100mg/ml phenylmethylsulfonyl fluoride and
30 mg/ml aprotinin, and homogenized by ultrasonication. Aliquots
of kidney tissue homogenate (50 mg) were subjected to assessment of
TGF-b1, fibronectin, and 8-hydroxy-20-deoxyguanosine expression
using immunoblotting.
Immunohistochemistry
Kidneys were fixed in 4% phosphate-buffered saline-buffered
formaldehyde, embedded in paraffin, and then sliced longitudinally
into 5-mm thick sections. Monoclonal antibodies against TGF-b1,
fibronectin, and 8-hydroxy-20-deoxyguanosine (Chemicon Interna-
tional Inc., Temecula, CA, USA) were used for immunohistochem-
istry. Immunoreactivity in sections was demonstrated using a
horseradish peroxidase-30-, 30-diaminobenzidine kit (R & D
Systems, Minneapolis, MN, USA) according to the manufacturer’s
instructions, followed by counterstaining with hematoxylin, dehy-
dration, and mounting. Sections without primary antibodies were
enrolled as negative controls for immunostaining.
Histomorphometry
Six regions within renal glomeruli from three sections obtained
from eight rats were studied. Five areas (3 mm2) containing positive
immunostained cells were microscopically and quantitatively
analyzed (Carl Zeiss, Gottingen, Germany). Three random images
of 0.75 mm2 from each selected region were then taken, captured,
and analyzed under  400 magnifications using a cool CCD camera
and image-analysis software (Media Cybernetics, Sliver Spring, MD,
USA). The number of positive immunolabeled cells in each area was
counted. Renal mesangial cells were identified morphologically.
Statistical analysis
All values were expressed as means7s.e.’s. The Wilcoxon test was
used to evaluate differences between each sample of interest and its
respective control. For analysis of time course, a multiple range
of analysis of variance and Bonferroni post hoc tests were used.
A P-value of o0.05 was considered statistically significant.
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